The dual FAK-HDAC inhibitor MY-1259 displays potent activities in gastric cancers in vitro and in vivo
Jian Song, Xu Liu, Yifan Zhang, Xin-Yi Tian, Mengyan Deng, Chen‐Zheng Huang, Sai‐Yang Zhang
Topics & Concepts
In vivoChemistryProtein kinase BFocal adhesionHDAC6Cancer researchIn vitroPhosphorylationPharmacologyPI3K/AKT/mTOR pathwayKinaseCell biologyHistone deacetylaseApoptosisBiochemistryBiologyHistoneGeneBiotechnologyHistone Deacetylase Inhibitors ResearchPeptidase Inhibition and AnalysisProtein Degradation and Inhibitors